INTRODUCTION
============

Since the atomic bombing at Hiroshima and Nagasaki in 1945, the genetic effects or damages caused by A-bomb radioactivity have been reported^[@b1-kjim-2-2-227-16]\~[@b3-kjim-2-2-227-16])^, and the first research on chromosomal aberration of A-bomb survivors was undertaken by Moorhead et al^[@b4-kjim-2-2-227-16])^. They first introduced the cyto-genetic method through culture of human peripheral blood.

It can be easily presumed that the damage to DNA in A-bomb surviors was due to their exposure to hundreds or thousands of atomic radioactivity of Rad.

Many Koreans who had been at Hiroshima and Nagasaki in Japan are well Known to have been damaged by the atomic bombings.

However, in korea, no investigation or study, has so far been made of genetic effects or damage by A-bomb radioactivity on Korean A-bomb survivors who returned from Hiroshima or Nagasaki.

In order to investigate the genetic effects or damage on the part of those A-bomb sufferers and their offspring for the first time in korea, we selected 50 cases at random from among 625 cases at Habchon county clinic for A-bomb sufferers in kyongsang Namdo province of Korea. Then we conducted both clinical and pathological tests for them, and applied chromosome-analysis by cytogenetic method both to 15 seriously damaged cases and 8 cases of their offspring.

SUBJECTS AND METHODS
====================

1. Subjects
-----------

Fifty cases (30 males, 20 females) were selected at random from among 625 cases, and were given both clinical and pathological examinations. Among them, 15 seriously damaged cases were given the chromosome-analysis, and 8 offspring of the 7 cases with high frequency of chromosomal breakages were tested for chromosomal changes and sister chromatid exchange (SCE) as well.

Age and Sex distribution of the subjects is shown in [Table 1](#t1-kjim-2-2-227-16){ref-type="table"}. Eight cases were offspring of 5 males and of 3 females. Age ranged from ten to twenty.

2. Methods
----------

Lymphocyte culture performed according to moorhead'^[@b4-kjim-2-2-227-16])^ macro-method: 10 cc of peripheral blood was taken aseptically, heparinized, and in 2 or 3 hours, separated Buffy coat was cultured for 72 hours in Eagle's Enriched Minimal Essential (MEM) containing antibiotics, fetal bovine serum and PHA.

One or two hours before the completion of culture, Colcemid (0.1 *μ*g/ml) was added to the cultured lymphocyte, treated with hypotonic solution (0.075 M Kcl), fixed with Carnoy's fixative, and final chromosomal samples were made out by air-dry method.

With these samples stained by 4% of giemsa solution (Gurr's R-66) unstable types of chromosomal aberration were examined by Seabright's^[@b5-kjim-2-2-227-16])^ Giemsa banding method.

The number of observed metaphases was 30 per subject and chromosomal aberration was analysed through microscopic photography. Control subjects were examined by the same methods for chromosomal change.

In order to analyze SCE in 8 cases of their offspring, chromosomal samples were designed in the same method by adding BUdR (5-Bromodeoxy uridine, Sigma, Ultimate concentration 10^−5^ M) after 24 hour culture of peripheral blood and by the further 48 hour culture.

In this study quite the same brand of materials was used since fetal bovine serum (FBS-309, Gibco), culturing solution, antibiotics, Colcemid and hypotonic solution could have different effects on frequencies of SCE. BUdR addition and the proceeding thereafter were preformed in the darkroom.

Chromosomal samples were kept in the darkroom for 7 days, and then stained with Hoechst 33258 (0.5 *μ*g/ml), exposed to UVL-56, Black Ray, Ultra-violet Products Inc., U.S., at the distance of 10 cm for 2 hours and finally stained with 4% of Giemsa for 5 to 6 minutes.

In order to analyze SCE, 14 to 18 metaphases were scored and final analysis was made by microscopic photograph (1000×) using minicopy film (ASA 25), and magnifying with Leitzphcomat II.

RESULTS
=======

All of the A-bomb exposed patients under observation were suffering from various diseases. 2 cases were suffering from malignant tumors, Viz., 1 case from stomach cancer, 1 case, cervical cancer ([Table 2](#t2-kjim-2-2-227-16){ref-type="table"}).

Laboratory findings are shown in [Tables 3](#t3-kjim-2-2-227-16){ref-type="table"} and [4](#t4-kjim-2-2-227-16){ref-type="table"}. However, these laboratory findings seemed to have more to do with their physical illness or nutritional state than their past exposure to the A-bomb itself.

The results of chromosomal analysis on the exposed showed no unstable types of chromosmal aberrations or stable types of chromosomal aberrations.

However, chromosomal breakage was observed in 7 out of 15 cases, which showed a significantly higher incidence of chromatid breakage than normal controls ([Table 5](#t5-kjim-2-2-227-16){ref-type="table"}, [Fig. 1](#f1-kjim-2-2-227-16){ref-type="fig"}).

The results of chromosomal analysis in 8 offspring showed no structural changes in chromsomes detected, but increased frequency of SCE.

That is, 6 cases showed a significantly higher rate of SCE as compared to that of normal controls; the range of SCE frequency in 8 offspring was 3.0 to 18.0, while that of normal controls was 3.3 to 8.8 ([Table 6](#t6-kjim-2-2-227-16){ref-type="table"}, [Fig. 2](#f2-kjim-2-2-227-16){ref-type="fig"}, [3](#f3-kjim-2-2-227-16){ref-type="fig"}).

DISCUSSION
==========

Muller^[@b7-kjim-2-2-227-16])^ suggested for the first time, in 1927, that mutation could be made artificially to find out the vinegar-fly's mutation caused by the exposure to X-ray. This was followed by researches by some scholars^[@b8-kjim-2-2-227-16],[@b9-kjim-2-2-227-16])^ on the relation of the irradiation of radioactive rays to mutation. Moorhead et al^[@b4-kjim-2-2-227-16])^ introduced the cyto-genetic method by culture of human peripheral blood and it has since led many researches to the study of chromosomal aberration in the atomic bomb survivors.

The cyto-genetic method has been applied to the investigation of genetic effects or damage due to the atomic bomb radioactivity since the atomic bombings at Hiroshima and Nagasaki^[@b10-kjim-2-2-227-16]\~[@b18-kjim-2-2-227-16])^. It is presumed that those A-bomb survivors were exposed to hundreds of radioactive rays and may be their DNA damaged.

Higher incidence of such diseases as malignant tumors, multiple myeloma and leukemia has been observed in those ever exposed to atomic radioactivity in many reports^[@b6-kjim-2-2-227-16],[@b19-kjim-2-2-227-16],[@b20-kjim-2-2-227-16])^.

This has also been identified in our study, viz., some malignant tumors were detected in 2 out of 50 A-bomb survivors.

It is assumed that damaged DNA could be responsible for genetic effects and those malignant tumors, judging from a number of studies published so far. But it has yet to be confirmed. All the cases under study were suffering from physical illness either serious or mild: 27.1% decrease in albumin and 36.7% increase in IgG of immune globulin were observed in LFT. These clinical and laboratory findings may have been due to physical damage or unfavorable nutrious conditions rather than A-bomb radiation.

Assuming that man's exposure to the radiation would be the cause of serious health problems such as downwardness in immunity or lifespan^[@b21-kjim-2-2-227-16],[@b22-kjim-2-2-227-16])^ however, it is considered necessary to make a steady and careful study of the effect by A-bomb radiation on human health.

In the analysis of chromosomes in 15 seriously affected cases, no aberrations in their number of structure were detected.

Seven out of 15 cases, however, showed a significantly higher incidence of chromatid breakage against normal controls. This higher incidence of chromatied breakage in the so-called chromosomal breakage syndrome such as Bloom's syndrome, ataxia telangiectasia, and xeroderma pigmentosa, showed a marked decrease in chromsomal stability^[@b23-kjim-2-2-227-16])^.

It is somewhat hard to conclude^[@b13-kjim-2-2-227-16],[@b24-kjim-2-2-227-16])^ that the higher frequency of chromatid breakage was entirely due to exposure to A-bomb radiation on the part of the survivors as many as 35 years ago.

One of the methods used in detecting damage or recovery of DNA in chromosome is the application of SCE, first used by Tayler' et al in 1957^[@b25-kjim-2-2-227-16])^ and then improved with the process of staining by Latt^[@b26-kjim-2-2-227-16],[@b27-kjim-2-2-227-16])^ and perry et al.^[@b28-kjim-2-2-227-16],[@b29-kjim-2-2-227-16])^

This method is often used as a device for detecting genetic factors of the environmental mutation today.

The sister chromatid exchange is known to occur at S period of the cellular cycle and regarded as a mutual exchange phenomenon occurring between homologous positions on double strands of DNA.

Since the frequency of SCE is increased not only by mutagen or carcinogen, but also by clastogen of chromatid breakage^[@b19-kjim-2-2-227-16]\~[@b21-kjim-2-2-227-16],[@b30-kjim-2-2-227-16],[@b31-kjim-2-2-227-16])^ the SCE could provide a parameter indicating DNA damage^[@b27-kjim-2-2-227-16],[@b32-kjim-2-2-227-16])^.

The analysis of chromosomes in the survivor's offspring whose chromatid breakage was investigated showed no aberration either in their number or structure and no difference of chromatid breakage between those subjects and normal controls. However, SCE frequency in 6 out of 8 offspring of the survivors increased in significant contrast to that of normal controls: 3.0 to 18.0 with the former against 3.3 to 8.8 with latter. This increase in SCE frequency of the offspring may not indicate aberration in chromosomal level but DNA damage in some of them, and suggests that some genetic changes would take place hereafter.

![Metaphase chromosomes of a peripheral lymphocyte from an A-bomb survivor, showing chromatid breakages (←).](kjim-2-2-227-16f1){#f1-kjim-2-2-227-16}

![Lymphocyte metaphase from an offspring of an A-bomb survivor showing abnormally high numbers of SCEs (←).](kjim-2-2-227-16f2){#f2-kjim-2-2-227-16}

![Average of SCE frequency per mataphase (0) and extreme values (I) of lymphocyte cultures from 3 "controls" (C) and 8 offsprings of A-bomb survivors; the numbers above the upper limit Indicate the numbers of metaphases anlysed in each case.](kjim-2-2-227-16f3){#f3-kjim-2-2-227-16}

###### 

Age and Sex Distribution of All Subjects

  Sex      Male   Female
  -------- ------ --------
  35--40   3      4
  41--50   3      8
  51--60   10     8
  61--70   12     0
  71--     2      0
                  
  Total    30     20

###### 

Prevalence of Disease in Victims

  Sex                    Male   Female   Total
  ---------------------- ------ -------- -------
  Respiratory            8      5        13
  Musculoskeletal        6      6        12
  Digestive              6      3        9
  ENT, Eye               4      3        7
  Cardiovascular         3      3        6
  Allergy                3      1        4
  Urogenital             4      --       4
  Endocrine, Metabolic   --     2        2
  Malignancy             --     2        2
  Miscellaneous          5      3        8
                                         
  Total                  39     28       67

###### 

LET Findings in Patients

                        Ranges     Average   Abnormal/Total cases (%)
  --------------------- ---------- --------- --------------------------
  Total protein (gm%)   5.4--7.4   6.35      9/48 (18.8)
  Albumin (gm%)         3.1--4.1   3.65      13/48 (27.1)
  GOT (IU)              5--92      17.50     3/48 (6.8)
  AK (K-AU)             4--120     9.56      10/45 (22.2)

###### 

Serum Immunoglobulin Levels in 22 Cases

        Ranges         Average   Abnormal/Total cases (%)
  ----- -------------- --------- --------------------------
  IgG   1,060--2,400   1554.5    8/22 (36.7)
  IgA   124--348       210.5     0/22 (0.0)
  IgM   116--350       207.9     3/22 (13.6)

###### 

Chromosome Breakage Frequency Data for 15 A-bomb Survivors, Based on the Number of Metaphases with Breakage (s). Possible Heterogeneity between the Control and Test Subjects was Tested Via Calculation of the "Hypergeometric" Probability

  Case      Sex/Age   Provisional diagnosis      n    nb   P value
  --------- --------- -------------------------- ---- ---- ---------
  Control   M         Normal                     50   2    
  1         M/68      Spinal stenosis            30   0    
  2         M/59      Bursitis at Lt. shoulder   30   4    0.025
  3         F/57      Congestive heart failure   30   5    0.009
  4         M/72      Bronchitis                 30   0    
  5         F/65      Psychosomatic disease      30   5    0.009
  6         F/57      Psychosomatic disease      30   0    
  7         F/67      Chronic bronchitis         30   3    
  8         M/60                                 30   7    
  9         M/68      Lt. mastoiditis            30   4    0.002
  10        M/?                                  30   6    0.025
  11        M/46      Both popliteal cyst        30   0    
  12        M/74      Neuralgia                  30   1    
  13        M/64      Sequence of C.V.A.         30   1    
  14        M/63                                 30   2    
  15        M/60      Irritable colon syndrome   30   4    0.025

n: Number of metaphases analysed

nb; Number of cells with chromosome breakage (s)

###### 

Comparison of SCE Frequencies (per metaphase) between Control and Test Subjects, with the "ANOVA" Tests of the Significance of the Difference

  Cases     n    Average SCE freq. per metaphase   Maximum/minimum values   SE      d.f.   Xi-Xm   Significance
  --------- ---- --------------------------------- ------------------------ ------- ------ ------- ----------------------------------------------------
  Control   60   5.90 ± 3.19                       3.3 -- 8.8                                      
   1        15   5.60 ± 2.02                       3.0 -- 10.0              0.488   33     0.30    
   2        18   7.56 ± 4.13                       3.0 -- 18.0              0.840   36     1.66    
   3        16   7.75 ± 1.42                       5.0 -- 10.0              0.469   34     1.85    [\*\*](#tfn5-kjim-2-2-227-16){ref-type="table-fn"}
   4        14   7.78 ± 2.65                       4.0 -- 13.0              0.758   32     1.88    [\*](#tfn4-kjim-2-2-227-16){ref-type="table-fn"}
   5        17   7.82 ±1.67                        5.0 -- 11.0              0.450   35     1.92    [\*\*](#tfn5-kjim-2-2-227-16){ref-type="table-fn"}
   6        18   8.17 ± 2.48                       4.0 -- 13.0              0.613   36     2.27    [\*\*](#tfn5-kjim-2-2-227-16){ref-type="table-fn"}
   7        16   8.81 ± 3.11                       5.0 -- 14.0              0.800   34     2.91    [\*\*](#tfn5-kjim-2-2-227-16){ref-type="table-fn"}
   8        16   9.38 ± 1.69                       6.0 -- 12.0              0.526   34     3.48    [\*\*](#tfn5-kjim-2-2-227-16){ref-type="table-fn"}

n: Stands for the number of metaphases scored

Significant at 0.05:

Significant at 0.01

SE: The standard error of the difference in SCE frequency between the means of control and subjects.
